Therapeutic Benefits of Putrescine-Modified Catalase in a Transgenic Mouse Model of Familial Amyotrophic Lateral Sclerosis

This publication has 77 references indexed in Scilit:

• Plasma Pharmacokinetics, Nervous System Biodistribution and Biostability, and Spinal Cord Permeability at the Blood–Brain Barrier of Putrescine-Modified Catalase in the Adult Rat
  Experimental Neurology, 1999
• Increased Permeability of Superoxide Dismutase at the Blood‐Nerve and Blood‐Brain Barriers with Retained Enzymatic Activity After Covalent Modification with the Naturally Occurring Polyamine, Putrescine
  Journal of Neurochemistry, 1996
• Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)
  Brain Research, 1995
• Neurodegenerative Disease: Oxidative stress and motorneuron disease
  Current Biology, 1994
• Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease
  Neuroscience Letters, 1994
• A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
  New England Journal of Medicine, 1994
• Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia.
  Stroke, 1994
• A radical hypothesis for neurodegeneration
  Trends in Neurosciences, 1993
• Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
  Nature, 1993
• Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia.
  Circulation, 1985